Quoin制药有限公司 (QNRX)在2023年第四季度财报电话会议后股价出现明显波动,公司详细介绍了财务表现、战略发展和未来展望。该股在前一交易日下跌6.45%后,盘前上涨2.08%。主要亮点包括大量现金储备、净亏损减少以及临床试验的进展。

Quoin Pharmaceuticals Ltd. (QNRX), a specialty pharmaceutical company currently valued at $2.42 million, announced today the initiation of the "NETHERTON NOW" campaign aimed at increasing awareness of ...

The recent 13% drop in Quoin Pharmaceuticals, Ltd.'s (NASDAQ:QNRX) stock could come as a blow to insiders who purchased US$580.9k worth of stock at an average buy price of US$0.48 over the past 12 ...

ASHBURN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty ...

(RTTNews) - Quoin Pharmaceuticals, Ltd. (QNRX) Tuesday announced positive interim clinical data from its ongoing Investigator Pediatric Netherton Syndrome clinical study using QRX003. The data ...

Quoin Pharmaceuticals Ltd. announced positive interim clinical data from an ongoing study of QRX003 for Netherton Syndrome, highlighting significant improvements in skin condition and patient ...

Quoin Pharmaceuticals (QNRX) announces further clinical evidence of the potential efficacy of QRX003 in Netherton Syndrome. In December 2024 and January 2025, Quoin announced data from the mid ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The boil water order is for everyone in the city of Du Quoin and the order is in effect immediately and will remain in effect ...